Parkinson’s UK calls on government to mark World Patient Safety Day
PharmaTimes
SEPTEMBER 21, 2023
The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
PharmaTimes
SEPTEMBER 21, 2023
The report outlines ways the government can help patients with Parkinson’s disease - News - PharmaTimes
Pharma Marketing Network
MAY 3, 2023
However, pharmaceutical marketing is also regulated by several agencies to ensure that patients are not exposed to false or misleading information. In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MAY 2, 2024
Following publication of this white paper, the government requested that the MHRA outline the steps the agency is working on in relation to its expectations. According to the MHRA, artificial intelligence offers “improved efficiencies”, enabling patients in the UK to safely access medical products earlier.
Clarivate
JUNE 29, 2023
We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.
Impetus Digital
JANUARY 30, 2023
Medications and supplies must be handled with the utmost care, often needing to comply with strict temperature regulations and changing demands from patients and providers that vary depending on the country. Add this to infrastructure challenges like cold storage or delays, and it’s no wonder patient needs are not always put first.
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
European Pharmaceutical Review
MARCH 12, 2024
Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. What is an effective solution?
pharmaphorum
JANUARY 27, 2023
Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.
World of DTC Marketing
JANUARY 8, 2021
At the time, pharmaceutical giant Pfizer and its partner BioNTech—which now have the other US-authorized COVID-19 vaccine—had inked a deal with the US government to supply doses at $19.50 Also, Johnson & Johnson had a deal to supply the US government with doses of its vaccine—still in the works—at a rate of $10 per dose.
Pharmaceutical Technology
OCTOBER 17, 2022
The UK Government has announced funding worth more than $894.6m (£800m) to back research into ground-breaking, experimental therapies and progress the response of the country to patient safety challenges. These research centres comprise a new facility in Exeter.
pharmaphorum
JANUARY 16, 2023
. “Although the totality of the data currently suggests that it is very unlikely that the signal…represents a true clinical risk, we believe it is important to share this information with the public, as we have in the past, when one of our safety monitoring systems detects a signal,” said the statement. 1 variant of Omicron.
World of DTC Marketing
JULY 21, 2021
Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 3hree: DTC marketing minimizes the side effects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.”
Pharmaceutical Technology
APRIL 3, 2023
Eisai and the National Cancer Center have signed an agreement to partner on investigator-initiated clinical research for the anti-cancer agent, tazemetostat (Tazverik Tablets 200 mg), based on the Patient-Proposed Healthcare Services system.
Legacy MEDSearch
JULY 21, 2023
UroMems , a global company developing innovative, mechatronics technology to treat stress urinary incontinence (SUI), announced today that it has successfully completed the first-ever implant of the UroActive smart, automated artificial urinary sphincter (AUS) in a female patient. Food and Drug Administration).
World of DTC Marketing
APRIL 15, 2021
While patients have the right to full disclosure, misinformation and scare tactics could lead to more deaths from COVID. Also cited was a lack of trust in the government to ensure the vaccines’ safety and effectiveness. The government allowed the drugmakers to mass-produce the vaccine while still conducting clinical trials.
World of DTC Marketing
OCTOBER 20, 2020
There has to be a complete investigation as to why the patient suffered ill effects including the possibility that he/she had a known or unknown health condition. “It’s troubling, to say the least, and I can’t recommend any vaccine to a patient until I know a hell of a lot more,” said one physician I talked to.
pharmaphorum
OCTOBER 26, 2022
And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.
Nixon Gwilt Law
APRIL 22, 2024
Its three separate Rules (Security, Privacy, and Breach) impose a variety of security controls, documentation, governance, and notice requirements on custodians of protected health information (PHI). The HTI-1 Final Rule is an AI disclosure and governance rule published by the US Department of Health and Human Services (HHS).
PM360
OCTOBER 28, 2022
With this in mind, in order to maximize the benefits of AI while mitigating its related risks, pharmaceutical incumbents and startups need to implement AI governance processes and tools. Likewise, it enables them to predict the effect of the compound on the target and the compound’s safety risks. Promising AI Use Cases in Pharma.
Pharmaceutical Technology
NOVEMBER 22, 2022
Additionally, a contract with the ministry for the Japanese government to procure one million courses of Xocova has become effective with the approval. The latest development is based on the expected efficacy of the drug and the acceptability of its safety profile reported from a Phase II/III clinical trial.
Pharmaceutical Technology
JULY 7, 2022
The two non-competing SARS-CoV-2 monoclonal neutralising antibodies, amubarvimab and romlusevimab are obtained from convalesced Covid-19 patients. The treatment is indicated for such patients who are at increased risk for disease progression, including hospital admission or mortality. 2 subvariants.
Celeritas
SEPTEMBER 26, 2022
A) Aiding Healthcare Professionals (HCPs): Storage of Patient Information: The common method of use of QR codes is in the organization and accessibility of patient records. In essence, patients’ files are all synced to a medical database. They’re ideal for monitoring elderly patients who tend to wander off or sleepwalk.
PM360
JUNE 11, 2022
Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. But 71% also want publicly shared information about how patients’ perspectives were incorporated into the development of products and services. Noël Moossa.
European Pharmaceutical Review
NOVEMBER 20, 2023
“This state-of-the-art parenteral site with the latest technology will enable us to continue to deliver medicines with safety first and quality always around the world,” stated Edgardo Hernandez, Executive Vice President and President of Eli Lilly’s manufacturing operations.
European Pharmaceutical Review
JUNE 16, 2023
The authors argued that fundamentally, implementation of AI/ML for pharmacovigilance has been hindered by the associated legal framework processes and governance issues. concluded: “If we do not harness the properties of data to allow us to leverage AI optimally, we will fail to do all we can for patient safety.” Bate et al.
European Pharmaceutical Review
NOVEMBER 15, 2022
According to IGBA, the World Health Organization ( WHO) Biosimilars Guideline has been a useful tool for health authorities to boost international regulatory convergence and consistency of terminology when evaluating biosimilars, by approving quality, safe and efficacious biosimilar medicines for patients who otherwise would have lacked access.
PM360
JUNE 26, 2023
This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations. In a shareholder meeting, Merck & Co.
Clarivate
MAY 24, 2022
Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]
European Pharmaceutical Review
OCTOBER 1, 2022
In order to carry out this work, the Council stated that governments must know which patient populations require supply and have accurate tissue and cell availability data to action this. Improving communication between public health authorities was also a key aim.
World of DTC Marketing
AUGUST 20, 2020
It’s estimated that between 30-40% of people won’t get the vaccine because they either don’t believe in vaccines or they have lost trust in our government to approve a safe and effective vaccine. Polls show that as the pandemic has continued, US citizens have become less confident about the safety of a vaccine.
European Pharmaceutical Review
DECEMBER 21, 2022
The Dutch government offers a prime example. Despite the tidal wave of renewed interest in psychedelic therapies, there is still much to be learned about them, including their precise mechanisms of action, their long- and short-term safety profiles, the durability of their effect, and their adverse effects—which can be severe.
Pharma Marketing Network
JULY 26, 2023
As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety.
Pharmaceutical Technology
MAY 25, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1.
Contrarian Sales Techniques
FEBRUARY 25, 2023
The film documents the efforts of activists, doctors, and patients to overcome these barriers and increase access to affordable treatment. This can result in shortages of certain medications, which can have serious consequences for patients who depend on those medications for their health.
Pharma Marketing Network
JANUARY 6, 2021
Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. Due to the pandemic, the healthcare industry has gone almost completely virtual Patient visits with HCPs, meetings between HCPs and sales reps, and healthcare conferences have all had to endure the virtual shift.
pharmaphorum
NOVEMBER 3, 2022
The two phase 3 studies – called EAGLE-2 and 3 – were stopped early by their data monitoring committees after an interim look at the data showed clear efficacy and safety for GSK’s drug. There are real concerns that we could be entering a post-antibiotic era, where even minor infections can be enough to kill patients.
Pharmaceutical Technology
DECEMBER 22, 2022
Theft, fraudulent prescriptions and unsanctioned distribution by patients and medical practitioners are the most common ways in which legal fentanyl products are illegally secured. Increased trafficking of illegal fentanyl represents a new threat to public health and safety. A lethal drug that creates its own demand.
Pharmaceutical Technology
MARCH 23, 2023
These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21. The agency reports that, in the pilot phase, these revisions halved the approval times for studies and cut the time from application to recruiting the first patient by 40 days.
Pharmaceutical Technology
JUNE 8, 2023
The core objective of the collaboration is to make the therapies affordable and accessible to patients. The companies will offer a comprehensive suite of cell therapy services to biotech, pharmaceutical and government entities, and to hospitals. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
pharmaphorum
NOVEMBER 24, 2022
The opportunity is open to academic, government, and industry organisations anywhere in the world, with a lead partner based in the UK. Dr Catherine Kettleborough, lead of the LifeArc Chronic Respiratory Infection Translational Challenge, said: “Repurposing an existing drug or compound is a faster way of getting new treatments to patients.
Contrarian Sales Techniques
FEBRUARY 24, 2023
In the blog post here , I’ve shared several tips to help patients cut down on costs, such as buying generic medications, shopping around for the best prices, and taking advantage of discounts and promotions offered by pharmacies. What is the hospital's patient-to-nurse ratio? What are the hospital's patient satisfaction rates?
European Pharmaceutical Review
AUGUST 23, 2022
FAKE MEDICINES are not a new problem, and pose a tremendous threat to patient safety and public health in society regardless of a country’s economic status. Unfortunately, such a chain of custody is not intended to provide patients with the ability to verify their own medicines. About the author.
Pharmaceutical Technology
JULY 25, 2022
Digitalization is now in full swing as medical care integrates with ICT to take the patient experience to the next level. There are already opportunities for patients to track their health through smart medical devices sending reports directly to their healthcare provider.
Clarity Engagement Solutions
NOVEMBER 9, 2020
The process of approval was simple: once the data showed the efficacy, safety and reliability to the regulatory agencies, the drug was approved. The goal is to create a collaborative relationship with stakeholders based around the development of the value propositions that address the needs of policy makers, patients and payers.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content